Eisai Co-promotes "PyloriTek(R) Test Kit", H. Pylori Infection Diagnostic Kit Launched by Sanko Junyaku.Tokyo, Japan, July 27, 2007 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) Newswire) - Sanko Junyaku Co., Ltd. today announced that it will launch the PyloriTek(R) Test Kit, a diagnostic kit for detecting Helicobacter pylori Helicobacter pylori A gramnegative rod-shaped bacterium that lives in the tissues of the stomach and causes inflammation of the stomach lining. Mentioned in: Indigestion, Ulcers Helicobacter pylori (H. pylori) infection in gastric biopsy specimens. The PyloriTek(R) Test Kit will be introduced to the market by Sanko Junyaku in September 2007 in co-promotion with its parent company Eisai Co., Ltd. H. pylori is a type of bacterium in the human stomach and has been known to be deeply associated with peptic ulcers Peptic ulcers Wounds in the stomach and duodenum caused by stomach acid and the bacterium Helicobacter pylori. Mentioned in: Tube Compression of the Esophagus and Stomach . The H. pylori eradication therapy has shown efficacy in reducing the risk for ulcer recurrence, providing a great benefit for patients. The PyloriTek(R) Test Kit is a diagnostic product used in the presumptive identification of H. pylori infection before and after the eradication therapy to evaluate infectious status of the patients. The PyloriTek(R) Test Kit shortens the diagnostic testing Diagnostic testing Testing performed to determine if someone is affected with a particular disease. Mentioned in: Von Willebrand Disease procedures due to the simplified preparation, enabling the test to start at the earliest opportunity. In addition, easier result evaluation can be made possible by the large reaction pad on which a positive reaction appears as an intense color change. Eisai Group established the Japan Business Headquarters in April 2007 which facilitates provision of information, services and products under the business strategy unified by all four domestic operations of Eisai Group (diagnostics/prescription pharmaceuticals/consumer healthcare products/generics). Eisai Co., Ltd. which co-promotes the PyloriTek(R) Test Kit has been marketing Pariet(R) (generic name: rabeprazole sodium), the company's core proton pump inhibitor proton pump inhibitor n. A class of drugs that inhibit gastric acid secretion by interfering with the movement of hydrogen ions across cell membranes and are used mainly to treat peptic ulcers, gastroesophageal reflux disease, and esophagitis. which is approved for H. pylori eradication therapy in combination with antibiotics. From diagnostics to treatment, Sanko Junyaku and Eisai provide a wide range of products and information for H. pylori infection, thereby making further contributions to the treatment of acid related disorders and improve the QOL QOL, n quality of life, a subjective assessment of one's emotional and physical well-being. (Quality of Life) of patients with peptic ulcers. About Eisai Co., Ltd. Eisai Co., Ltd. (TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). : 4523; ADR ADR - Astra Digital Radio : ESALY) is a research-based human health care company that discovers, develops and markets products in more than 30 countries. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide health care system. Eisai employs more than 8,000 people worldwide. For more information, please visit http://www.eisai.co.jp. Source: Eisai Co., Ltd. Contact: Kazunori Nishina Investor Relations, Sanko Junyaku Co., Ltd. TEL: +81-3-3865-4311 Corporate Communications Department, Eisai Co., Ltd. TEL: +81-3-3817-5120 Japan Corporate News Network. All rights reserved. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion